Terms: = Breast cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Treatment
176 results:
1. Omission of adjuvant radiotherapy in low-risk elderly males with breast cancer.
Vo K; Ladbury C; Yoon S; Bazan J; Glaser S; Amini A
Breast Cancer; 2024 May; 31(3):485-495. PubMed ID: 38507145
[TBL] [Abstract] [Full Text] [Related]
2. Impact of HER2-low expression on the efficacy of endocrine therapy with or without CDK4/6 inhibitor in HR-positive/HER2-negative metastatic breast cancer: A prospective study.
Wu Y; Mo H; Xu H; Wang Y; Wang J; Ma F; Xu B
Thorac Cancer; 2024 Apr; 15(12):965-973. PubMed ID: 38480513
[TBL] [Abstract] [Full Text] [Related]
3. Who can benefit from postmastectomy radiotherapy among HR+/HER2- T1-2 N1M0 breast cancer patients? An explainable machine learning mortality prediction based approach.
Jin L; Zhao Q; Fu S; Zhang Y; Wu S; Li X; Cao F
Front Endocrinol (Lausanne); 2024; 15():1326009. PubMed ID: 38375194
[TBL] [Abstract] [Full Text] [Related]
4. Long noncoding RNA SNHG1 promotes breast cancer progression by regulating the miR-641/RRS1 axis.
Deng L; Wang J; Song J; Wu Q; Gong Z; Song J; Hou L
Sci Rep; 2024 Feb; 14(1):3265. PubMed ID: 38331968
[TBL] [Abstract] [Full Text] [Related]
5. Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial.
Wang H; Yee D; Potter D; Jewett P; Yau C; Beckwith H; Watson A; O'Grady N; Wilson A; Brain S; Pohlmann P; ; Blaes A
Breast Cancer Res Treat; 2024 Apr; 204(3):589-597. PubMed ID: 38216819
[TBL] [Abstract] [Full Text] [Related]
6. Bisbenzylisoquinoline alkaloid fangchinoline derivative HY-2 inhibits breast cancer cells by suppressing blm DNA helicase.
Zhang W; Yu X; Bao L; He T; Pan W; Li P; Liu J; Liu X; Yang L; Liu J
Biomed Pharmacother; 2023 Dec; 169():115908. PubMed ID: 37988849
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy of breast reconstruction for N2-3M0 stage female breast cancer on breast cancer-specific survival: A population-based propensity score analysis.
Zhao Y; Yan L; Li S; Yang Z; Chai N; Qiu P; Zhang H; He J; Zhou C
Cancer Med; 2023 Oct; 12(20):20287-20298. PubMed ID: 37795774
[TBL] [Abstract] [Full Text] [Related]
8. ExpHBA Deep-IoT: Exponential Honey Badger Optimized Deep Learning For breast cancer Detection in IoT Healthcare System.
Rajeswari R; Sriramakrishnan GV; Ch Vidyadhari ; Kanimozhi KV
J Digit Imaging; 2023 Dec; 36(6):2461-2479. PubMed ID: 37491544
[TBL] [Abstract] [Full Text] [Related]
9. Phase-separated ribosome-nascent chain complexes in genotoxic stress response.
Németh-Szatmári O; Nagy-Mikó B; Györkei Á; Varga D; Kovács BBH; Igaz N; Bognár B; Rázga Z; Nagy G; Zsindely N; Bodai L; Papp B; Erdélyi M; Kiricsi M; Blastyák A; Collart MA; Boros IM; Villányi Z
RNA; 2023 Oct; 29(10):1557-1574. PubMed ID: 37460154
[TBL] [Abstract] [Full Text] [Related]
10. Identification of Hub Genes and Upstream Regulatory Factors Based on Cell Adhesion in Triple-negative breast cancer by Integrated Bioinformatical Analysis.
Han YH; Wang Y; Lee SJ; Mao YY; Jiang P; Sun HN; Jin MH; Kwon T
Anticancer Res; 2023 Jul; 43(7):2951-2964. PubMed ID: 37351977
[TBL] [Abstract] [Full Text] [Related]
11.
Gupta N; Huang TT; Nair JR; An D; Zurcher G; Lampert EJ; McCoy A; Cimino-Mathews A; Swisher EM; Radke MR; Lockwood CM; Reichel JB; Chiang CY; Wilson KM; Cheng KC; Nousome D; Lee JM
Sci Transl Med; 2023 Jun; 15(701):eadd7872. PubMed ID: 37343085
[TBL] [Abstract] [Full Text] [Related]
12. Adjuvant and neoadjuvant therapy with cyclin-dependent kinase 4 and 6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer: a systematic review and meta-analysis.
Zhang M; Song J; Guo S; Jin F; Zheng A
Endocr Relat Cancer; 2023 Aug; 30(8):. PubMed ID: 37283514
[TBL] [Abstract] [Full Text] [Related]
13. Imaging in metastatic breast cancer, CT, PET/CT, MRI, WB-DWI, CCA: review and new perspectives.
Lother D; Robert M; Elwood E; Smith S; Tunariu N; Johnston SRD; Parton M; Bhaludin B; Millard T; Downey K; Sharma B
Cancer Imaging; 2023 May; 23(1):53. PubMed ID: 37254225
[TBL] [Abstract] [Full Text] [Related]
14. HORMONE-RECEPTOR -POSITIVE breast cancer: DIFFERENT PROGNOSIS OF BONE METASTASIS AMONG MOLECULAR SUBTYPES.
Tevzadze M; Kakhadze S; Baramia M; Rukhadze T; Khatashvili Z; Mirzaey S
Georgian Med News; 2023 Mar; (336):54-58. PubMed ID: 37166880
[TBL] [Abstract] [Full Text] [Related]
15. Biomarkers predicting clinical outcomes in nasopharyngeal cancer patients receiving immune checkpoint inhibitors: A systematic review and meta-analysis.
Qian X; Chen H; Tao Y
Front Immunol; 2023; 14():1146898. PubMed ID: 37063822
[TBL] [Abstract] [Full Text] [Related]
16. Changes in breast cancer staging trends among Egyptian women after COVID-19: A retrospective single-center study.
Abd El Wahab MH; Ibrahim AH; Gado O; Bahbah AM; Fadlalla W; Fakhry S; Mamdouh MM; Kamel MM; Moaz I; Rabea A; Helal AM
Int J Immunopathol Pharmacol; 2023; 37():3946320231152835. PubMed ID: 36649477
[TBL] [Abstract] [Full Text] [Related]
17. Quality-of-life outcomes following topical melatonin application against acute radiation dermatitis in patients with early breast cancer: A double-blind, randomized, placebo-controlled trial.
Zetner D; Kamby C; Gülen S; Christophersen C; Paulsen CB; Piga E; Hoffmeyer B; Mahmood F; Rosenberg J
J Pineal Res; 2023 Jan; 74(1):e12840. PubMed ID: 36385713
[TBL] [Abstract] [Full Text] [Related]
18. Integration of Universal Germline Genetic Testing for All New breast cancer Patients.
Culver JO; Freiberg Y; Ricker C; Comeaux JG; Chang EY; Banerjee V; Sturgeon D; Solomon I; Kagey J; Dobre MG; Carey J; Carr A; Cho S; Lu J; Kang IM; Patel K; Terando A; Ye JC; Li M; Lerman C; Spicer D; Nelson M
Ann Surg Oncol; 2023 Feb; 30(2):1017-1025. PubMed ID: 36161375
[TBL] [Abstract] [Full Text] [Related]
19. Evaluation of Real-world Data for breast-MRI BI-RADS IV Lesions.
Hachenberg J; Steinkasserer L; Malter W; Thangarajah F; Warm M; Gossmann A; Brod M; Pahmeyer C; Eichler C
In Vivo; 2022; 36(5):2255-2259. PubMed ID: 36099097
[TBL] [Abstract] [Full Text] [Related]
20. Screening, characterization and anti-cancer application of purified intracellular MGL.
Sharma B; Devi S; Kumar R; Kanwar SS
Int J Biol Macromol; 2022 Sep; 217():96-110. PubMed ID: 35817235
[TBL] [Abstract] [Full Text] [Related]
[Next]
